Bootstrapped UNC spinout lands $300K for gene therapy work

After bootstrapping for nearly two years, the CEO of a UNC-Chapel Hill spinout developing gene therapies has scored financial support.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.